Decoy Therapeutics issued a correction to its earlier announcement regarding a warrant inducement transaction. The company clarified that the new unregistered warrants to purchase up to 2,368,868 shares of common stock will become exercisable immediately upon issuance, without requiring stockholder approval. These warrants will expire five years from issuance. This correction ensures investors have accurate information about the warrant terms, which could impact investment decisions. Decoy Therapeutics continues to develop antiviral drugs using its proprietary platform targeting multiple respiratory viruses.
Decoy Therapeutics' recent correction clarifies warrant inducement terms but is not linked to Pluang-traded assets. For readers following the health sector, here is Pluang's market snapshot as of Sep 23, 2026 05:11 WIB: Among 101 priced health-sector US stocks, 69 rose and 32 fell. Notable movers include FLNA at USD 0.95 with a 29.14% increase and a typical hold time of 37 days, DNA at USD 9.34 up 17.04% with a 10-day hold, and CLPT at USD 16.05 rising 14.89% but with 100% sell order activity.
A Vice President at WM sold 1,365 shares valued at $300,000. Insider sales like this can indicate the executive's personal financial decisions but do not necessarily reflect the company's outlook. Investors should watch for any further insider activi...
Leidos Holdings was upgraded from Hold to Buy following strong Q2 2026 earnings, with growth in Defense, Homeland, and Intelligence & Digital segments offsetting weakness in Health. The company’s backlog rose to $48.7 billion, with funded backlog up ...
YETI has raised its fiscal year 2026 guidance, now expecting 10-12% growth in adjusted operating income, 14.9% operating margins, and pro forma EPS of $2.94-$3.00. The company benefits from accelerating direct-to-consumer sales, strong 19% year-over-...
Bitcoin Cash surged 28.76% to $341.18, leading the day's top gainers amid renewed interest driven by discussions of potential network upgrades. This rise highlights investor focus on scalable alternatives to Bitcoin, as Bitcoin Cash offers larger blo...
Useless Coin (USELESS) has surged significantly in the past 24 hours, outperforming the broader crypto market which rose 4.2% to a $2.91 trillion market cap. This rally is driven by Bitcoin's breakout and a rotation of capital into memecoins like PEP...
